The validity and precision of the leicester cough questionnaire in COPD patients with chronic cough

Health and Quality of Life Outcomes

Volumn 10, Issue , 2012, Pages

  Berkhof, Farida F ^a   Boom, Lisenka N ^a   ten Hertog, Nynke E ^a   Uil, Steven M ^a   Kerstjens, Huib A M ^b   van den Berg, Jan W K ^a  

^a ISALA HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

COPD; Cough; Health status; LCQ; Validity

Indexed keywords

ACCURACY; AGED; ARTICLE; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; FEMALE; HUMAN; INTERNAL CONSISTENCY; LEICESTER COUGH QUESTIONNAIRE; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; REPRODUCIBILITY; SHORT FORM 36; TEST RETEST RELIABILITY; VALIDITY; AGE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; FOLLOW UP; MIDDLE AGED; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEX DIFFERENCE; STANDARD; TREATMENT OUTCOME; VALIDATION STUDY;

AZITHROMYCIN;

AGE FACTORS; AZITHROMYCIN; CHRONIC DISEASE; COUGH; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SEX FACTORS; TREATMENT OUTCOME;

EID: 84855514032     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-10-4     Document Type: Article

References (35)

1. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007, 370(9589):765-73. 10.1016/S0140-6736(07)61380-4, 17765526.
2. Smith JA, Calverley PM. Cough in chronic obstructive pulmonary disease. Pulm Pharmacol Ther 2004, 17(6):393-8. 10.1016/j.pupt.2004.09.006, 15564082.
3. Rodriguez-Roisin R, Anzueto A, Bourbeau J, Calverley P, deQuia TS, Fukuchi Y, et al. Global initiative for chronic obstructive lung disease. Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease Updated 2009. Accessed on http://www.goldcopd.com.
4. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007, 176(6):532-55. 10.1164/rccm.200703-456SO, 17507545.
5. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004, 364(9435):709-21. 10.1016/S0140-6736(04)16900-6, 15325838.
6. Viegi G, Pistelli F, Sherrill DL, Maio S, Baldacci S, Carrozzi L. Definition, epidemiology and natural history of COPD. Eur Respir J 2007, 30(5):993-1013. 10.1183/09031936.00082507, 17978157.
7. Chung KF, Pavord ID. Prevalence, pathogenesis, and causes of chronic cough. Lancet 2008, 371(9621):1364-74. 10.1016/S0140-6736(08)60595-4, 18424325.
8. Patel IS, Vlahos I, Wilkinson TM, Lloyd-Owen SJ, Donaldson GC, Wilks M, et al. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004, 170(4):400-7. 10.1164/rccm.200305-648OC, 15130905.
9. Burgel PR, Nesme-Meyer P, Chanez P, Caillaud D, Carre P, Perez T, Roche N. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest 2009, 135(4):975-82. 10.1378/chest.08-2062, 19017866.
10. Menn P, Weber N, Holle R. Health-related quality of life in patients with severe COPD hospitalized for exacerbations - comparing EQ-5D, SF-12 and SGRQ. Health Qual Life Outcomes 2010, 8:39. 10.1186/1477-7525-8-39, 2864208, 20398326.
11. Crawford B, Monz B, Hohlfeld J, Roche N, Rubin B, Magnussen H, et al. Development and validation of a cough and sputum assessment questionnaire. Respir Med 2008, 102(11):1545-55. 10.1016/j.rmed.2008.06.009, 18662868.
12. French CT, Irwin RS, Fletcher KE, Adams TM. Evaluation of a cough-specific quality-of-life questionnaire. Chest 2002, 121(4):1123-31. 10.1378/chest.121.4.1123, 11948042.
13. Leidy NK, Rennard SI, Schmier J, Jones MK, Goldman M. The breathlessness, cough, and sputum scale: the development of empirically based guidelines for interpretation. Chest 2003, 124(6):2182-91. 10.1378/chest.124.6.2182, 14665499.
14. Baiardini I, Braido F, Fassio O, Tarantini F, Pasquali M, Tarchino F, et al. A new tool to assess and monitor the burden of chronic cough on quality of life: Chronic Cough Impact Questionnaire. Allergy 2005, 60(4):482-8. 10.1111/j.1398-9995.2005.00743.x, 15727580.
15. Au DH, Blough DK, Kirchdoerfer L, Weiss KB, Udris EM, Sullivan SD. Development of a quantifiable symptom assessment tool for patients with chronic bronchitis: the Chronic Bronchitis Symptoms Assessment Scale. COPD 2005, 2(2):209-16. 10.1081/COPD-57580, 17136947.
16. Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax 2003, 58(4):339-43. 10.1136/thorax.58.4.339, 1746649, 12668799.
17. Huisman AN, Wu MZ, Uil SM, van den Berg JW. Reliability and validity of a Dutch version of the Leicester Cough Questionnaire. Cough 2007, 3:3. 10.1186/1745-9974-3-3, 1804278, 17313670.
18. Ma W, Yu L, Wang Y, Li X, Lu H, Qiu Z. Changes in health-related quality of life and clinical implications in Chinese patients with chronic cough. Cough 2009, 5:7. 10.1186/1745-9974-5-7, 2760496, 19781068.
19. Murray MP, Turnbull K, MacQuarrie S, Pentland JL, Hill AT. Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis. Eur Respir J 2009, 34(1):125-31. 10.1183/09031936.00160508, 19196812.
20. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992, 145(6):1321-7.
21. Engstrom CP, Persson LO, Larsson S, Sullivan M. Reliability and validity of a Swedish version of the St George's Respiratory Questionnaire. Eur Respir J 1998, 11(1):61-6. 10.1183/09031936.98.11010061, 9543271.
22. Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T, Westlake L. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992, 305(6846):160-4. 10.1136/bmj.305.6846.160, 1883187, 1285753.
23. Mahler DA, Mackowiak JI. Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with COPD. Chest 1995, 107(6):1585-9. 10.1378/chest.107.6.1585, 7781351.
24. Perneger TV, Leplege A, Etter JF, Rougemont A. Validation of a French-language version of the MOS 36-Item Short Form Health Survey (SF-36) in young healthy adults. J Clin Epidemiol 1995, 48(8):1051-60. 10.1016/0895-4356(94)00227-H, 7775992.
25. Montazeri A, Goshtasebi A, Vahdaninia M, Gandek B. The Short Form Health Survey (SF-36): translation and validation study of the Iranian version. Qual Life Res 2005, 14(3):875-82. 10.1007/s11136-004-1014-5, 16022079.
26. Anderson C, Laubscher S, Burns R. Validation of the Short Form 36 (SF-36) health survey questionnaire among stroke patients. Stroke 1996, 27(10):1812-6. 10.1161/01.STR.27.10.1812, 8841336.
27. Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007, 60(1):34-42. 10.1016/j.jclinepi.2006.03.012, 17161752.
28. Streiner David L, Norman Geoffrey R. Health measurement scales: A practical guide to their development and use. 2003, Oxford University Press.
29. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 1(8476):307-10.
30. Locker D. Oral health and quality of life. Oral Health Prev Dent 2004, 2(Suppl 1):247-53.
31. Raj AA, Pavord DI, Birring SS. Clinical cough IV:what is the minimal important difference for the Leicester Cough Questionnaire?. Handb Exp Pharmacol 2009, (187):311-20.
32. Brokkaar L, Uil SM, van den Berg JW. Minimal Clinically Important Difference (MCID) of the dutch version of the Leicester Cough Questionnaire and baseline predictors of reaching the MCID after six months. Chest 2007, 132:468b.
33. Polley L, Yaman N, Heaney L, Cardwell C, Murtagh E, Ramsey J, et al. Impact of cough across different chronic respiratory diseases: comparison of two cough-specific health-related quality of life questionnaires. Chest 2008, 134(2):295-302.
34. Rutten-van MM, Roos B, Van Noord JA. An empirical comparison of the St George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting. Thorax 1999, 54(11):995-1003. 10.1136/thx.54.11.995, 1745382, 10525558.
35. Daudey L, Peters JB, Molema J, Dekhuijzen PN, Prins JB, Heijdra YF, Vercoulen JH. Health status in COPD cannot be measured by the St George's Respiratory Questionnaire alone: an evaluation of the underlying concepts of this questionnaire. Respir Res 2010, 11:98. 10.1186/1465-9921-11-98, 2919469, 20649991.